Much progress has been made in understanding the developmental roles of Eph receptor tyrosine kinases and their membrane-bound ligands, ephrins. Interactions between these molecules fall largely into two classes: EphA receptors (of which there are eight family members) bind promiscuously to glycosylphosphatidylinositol (GPI)-anchored ephrin-A ligands (five members), whereas EphB receptors (six members) bind to transmembrane ephrin-B ligands (five members) [1] ; see [2] for nomenclature. Functional analyses have revealed key roles for these proteins in the regulation of repulsion or adhesion responses that guide axons and cells along specific pathways (reviewed in [3, 4] ), restrict cell intermingling [5] and underlie remodelling of blood vessels [6, 7] . Understanding the function of these molecules requires knowledge of their developmental expression patterns; an important and widely used technique for this has been the use of fusions comprising the extracellular domain of Eph receptors or ephrins and alkaline phosphatase or the Fc portion of IgG (IgG-Fc). Because of the promiscuous binding between members of each class of Eph receptors and members of their corresponding class of ligands, the soluble fusion proteins can detect expression of the corresponding class of ephrins or Eph receptors by wholemount staining of embryos. This technique has revealed gradients of ephrin expression in the tectum that underlie topographic mapping [8, 9] , and a general complementary expression of Eph receptors and ephrins, which suggests a role for these proteins in compartmentalising the embryo [1] . Although in situ hybridisation confirmed the existence of gradients and complementarity in the expression of specific Eph-receptor and ephrin mRNAs, it has also revealed some overlaps in expression [7, 10, 11] . This discrepancy raises the question of whether the patterns detected by the fusion proteins give an accurate Magazine R469 Figure 1 (a-j) The left and right columns show wildtype and eA5-transgenic mouse embryos, respectively, stained with various reagents to detect Eph receptors or ephrins (as indicated). (a-d) Whole 9.5-10 day old embryos and higher power views of (e-h) the tail bud and (i,j) the midbrain are shown. Published methods were used to stain with Fc fusion proteins [1] and the anti-EphA4 antibody [15] . M, midbrain; hb, hindbrain; di, diencephalon; t, tail bud; s, somites. (k) Diagram illustrating the gradients of ephrin-A and EphA-receptor expression and the location at which ephrin has been fully masked by the Eph receptor (solid arrow in (i,k)). (l) After transgenic expression of ephrin-A5, the location at which ephrin-A proteins have been fully masked has shifted anteriorly (solid arrow in j,l) compared with the position in wild-type embryos (dotted arrow). A, anterior; P, posterior. During studies of ephrin function, we generated a transgenic line of mice (termed eA5 transgenic) in which a β-actin promoter drives ubiquitous ectopic expression of ephrin-A5. We stained control ( Figure 1a ) and transgenic (Figure 1b ) embryos using EphA4-Fc and detected ectopic expression of ephrin-A protein throughout eA5-transgenic embryos, except at specific sites such as the tail mesoderm and the hindbrain. Because the latter are known sites for the expression of EphA receptors, we attempted to detect EphA receptor proteins by staining embryos with ephrin-A5-Fc. We found that, compared with control embryos (Figure 1c) , the detection of EphA receptors in eA5-transgenic embryos (Figure 1d ) was severely diminished in many tissues, including the tail mesoderm (see also Figure 1e ,f), the dorsal part of somites, the diencephalon and the anterior midbrain. One explanation for this result is that EphA receptors were bound to membrane-bound ephrin-A5, and were thus masked from the soluble ephrin-A5 fusion protein, which was at a lower effective concentration. Alternatively, an increased turnover of activated receptors could have led to lower levels of EphA receptor at sites of overlap. To distinguish between these two possibilities, we used an antibody against the intracellular domain of EphA4 and found that there were similar levels of EphA4 protein in, for example, the tail mesoderm of control and eA5-transgenic embryos (Figure 1g,h) .
Although some sites of EphA expression were masked by ectopically expressed ephrin-A5, others, such as the hindbrain, were not. Similarly, endogenous EphA receptors masked ephrin-A5 in some sites but not in others. This may reflect the relative concentrations of Eph receptor and ephrin, such that only the component present in excess over the other is detected.
The staining patterns in the midbrain are consistent with this. Ephrin-A5 and ephrin-A2 are expressed in a posterior-anterior gradient in the midbrain [8, 9] , and there is a counter-gradient of the corresponding receptors [11] . Detection with EphA4-Fc revealed this ephrin-A gradient and a sharp anterior boundary. Compared with control embryos (Figure 1i) , the boundary is more anterior in eA5-transgenic embryos (Figure 1j ) because the elevation of ephrin-A5 expression shifts the position at which it is masked by the EphA receptors (Figure 1k,l) .
These data indicate that at sites of overlap, Eph receptors and ephrins are largely bound to each other, possibly by clustering to sites of cell contact [12] . Although staining with Eph and ephrin fusion proteins has provided initial clues to their expression patterns, it is important to appreciate that this technique exaggerates the complementarity. Overlapping expression is likely to be of functional significance because in the retina it leads to persistent Eph-receptor activation [11] , which through desensitisation of a repulsion response is required for topographic mapping [13] . Overlapping expression also occurs in endothelial cells [7] , and it is possible that persistent activation of Eph receptors underlies an adhesion response [14] . It is therefore essential to detect any sites of overlapping expression by in situ hybridisation and immunocytochemistry.
